CPT-157633, a difluoro-phosphonomethyl phenylalanine derivative, and is a PTP1B inhibitor. CPT-157633 prevents binge drinking-induced glucose intolerance.
In Vivo
CPT-157633 (0.2 µg/day; intracerebroventricular infusion) alleviates the hypothalamic inflammation and glucose intolerance induced by binge drinking in rats . MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
その他の情報
| CAS | 888213-72-7 |
|---|---|
| 仕様と純度 | ≥99% |
| 保管条件 | Store at 2-8°C,Desiccated |
| 入荷 | Wet ice |
| Product Description | CPT-157633, a difluoro-phosphonomethyl phenylalanine derivative, and is a PTP1B inhibitor. CPT-157633 prevents binge drinking-induced glucose intolerance. In Vivo CPT-157633 (0.2 µg/day; intracerebroventricular infusion) alleviates the hypothalamic inflammation and glucose intolerance induced by binge drinking in rats . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid |
| 溶解度 | DMSO : 200 mg/mL (429.92 mM; Need ultrasonic) H2O : 100 mg/mL (214.96 mM; Need ultrasonic) |
レビュー
顧客レビュー
Remind me later